Microba Life Sciences Limited (ASX:MAP) Insider Pasquale (Paddy) Rombola Acquires 200,000 Shares

Microba Life Sciences Limited (ASX:MAP) insider Pasquale (Paddy) Rombola acquired 200,000 shares of the company’s stock in a transaction dated Tuesday, November 19th. The stock was purchased at an average cost of A$0.17 ($0.11) per share, with a total value of A$34,200.00 ($22,352.94).

Microba Life Sciences Price Performance

The company has a debt-to-equity ratio of 3.84, a current ratio of 2.61 and a quick ratio of 6.50.

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.